Legal Representation
Attorney
MICHELLE ELIZABETH LEGIEC
USPTO Deadlines
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 4, 2016 | MAB5 | O | ABANDONMENT NOTICE MAILED - AFTER PUBLICATION | Loading... |
| Aug 4, 2016 | ABN5 | O | ABANDONMENT - AFTER PUBLICATION | Loading... |
| Jul 18, 2016 | ISPO | Z | WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST | Loading... |
| May 31, 2016 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 31, 2016 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 23, 2016 | EXAR | I | TEAS EXPRESS ABANDONMENT RECEIVED | Loading... |
| May 11, 2016 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 28, 2016 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Apr 21, 2016 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Apr 9, 2016 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 8, 2016 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 8, 2016 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 8, 2016 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 3, 2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 3, 2016 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 3, 2016 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Apr 2, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 22, 2015 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Dec 21, 2015 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 19, 2015 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Additional Information
Design Mark
The mark consists of the word "Kangio" in black above the words "(bivalirudin) injection" in gray. Directly to the left of the word "Kangio" is a stylized mercury drop consisting of the color gray and black.
Color Claim
Color is not claimed as a feature of the mark.
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"BIVALIRUDIN INJECTION"